Antimicrobial Activity of Medicinal Plant Extracts against Multidrug-Resistant Staphylococcus aureus
CHAPTER ONE
1.0 Background of the Study
The rise of antibiotic-resistant bacteria is one of the most pressing global health problems today. Staphylococcus aureus is a common pathogen responsible for various infections, including skin wounds, pneumonia, and bloodstream infections. In recent years, the emergence of multidrug-resistant (MDR) strains such as Methicillin-Resistant Staphylococcus aureus (MRSA) has made treatment more difficult and costly (World Health Organization, 2022).
The overuse and misuse of antibiotics in medicine and agriculture have accelerated the development of resistance. As a result, there is a growing interest in exploring alternative antimicrobial agents from natural sources. Medicinal plants have long been used in traditional medicine for treating infectious diseases. They contain bioactive compounds such as alkaloids, flavonoids, tannins, and phenolics, which possess antimicrobial properties (Cowan, 1999).
Studying plant extracts for antimicrobial potential offers a sustainable and affordable approach to combating resistant pathogens. Unlike synthetic drugs, plant-derived compounds may have multiple mechanisms of action, making it harder for bacteria to develop resistance. Therefore, screening medicinal plants for activity against multidrug-resistant S. aureus is both relevant and timely.
1.1 Statement of the Problem
Antibiotic resistance in S. aureus has become a serious clinical challenge. Many infections that were once easily treatable now require prolonged hospital stays and more expensive therapies. In some regions, the availability of effective antibiotics is limited, leaving patients vulnerable to persistent infections.
While synthetic antibiotics continue to lose effectiveness, natural remedies remain underexplored. There is limited scientific data on the antimicrobial potency of local medicinal plants against resistant S. aureus strains. Hence, there is a strong need to evaluate plant extracts as possible alternatives or complementary agents to existing antibiotics.
1.2 Aim and Objectives of the Study
Aim:
To evaluate the antimicrobial activity of selected medicinal plant extracts against multidrug-resistant Staphylococcus aureus.
Objectives:
-
To collect and prepare extracts from selected medicinal plants.
-
To isolate and confirm multidrug-resistant S. aureus from clinical or environmental samples.
-
To determine the antimicrobial activity of the plant extracts using standard laboratory techniques.
-
To compare the effectiveness of the plant extracts with conventional antibiotics.
-
To identify the most active plant extract with potential for further development.
1.3 Significance of the Study
This study will contribute to the search for new and effective antimicrobial agents from natural sources. The findings will help validate the traditional use of medicinal plants in treating infections. They will also provide scientific evidence supporting the development of plant-based antimicrobial drugs.
Furthermore, the research will raise awareness about the dangers of antibiotic resistance and encourage the use of natural alternatives. It may also inspire future studies on isolating and characterizing specific bioactive compounds responsible for antimicrobial activity.
1.4 Scope of the Study
The study will focus on testing selected medicinal plant extracts, such as Azadirachta indica (neem), Ocimum gratissimum (scent leaf), and Zingiber officinale (ginger), against multidrug-resistant S. aureus. Laboratory analyses will include bacterial isolation, antibiotic susceptibility testing, and antimicrobial assays of the extracts. The study will not cover purification or chemical characterization of the active compounds. The emphasis will remain on comparative antimicrobial efficacy.